Literature DB >> 18032125

NICE recommendations for the prevention of osteoporotic fractures in postmenopausal women.

Pierre D Delmas1, Ethel S Siris.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 18032125     DOI： 10.1016/j.bone.2007.10.020

Source DB:  PubMed          Journal:  Bone        ISSN： 1873-2763            Impact factor:   4.398


× No keyword cloud information.
  7 in total

1.  NICE continues to muddy the waters of osteoporosis.

Authors:  J A Kanis; J E Compston
Journal:  Osteoporos Int       Date:  2008-06-05       Impact factor: 4.507

2.  NICE: Its Influence in Treating Osteoporosis in the UK and beyond.

Authors:  Juliet Compston
Journal:  Ther Adv Musculoskelet Dis       Date:  2009-04       Impact factor: 5.346

3.  Assessing the risk of osteonecrosis of the jaw due to bisphosphonate therapy in the secondary prevention of osteoporotic fractures.

Authors:  F Lapi; F Cipriani; A P Caputi; G Corrao; A Vaccheri; M C Sturkenboom; M Di Bari; D Gregori; F Carle; T Staniscia; A Vestri; M Brandi; V Fusco; G Campisi; G Mazzaglia
Journal:  Osteoporos Int       Date:  2012-05-23       Impact factor: 4.507

Review 4.  Ibandronate: a review of its use in the management of postmenopausal osteoporosis.

Authors:  James E Frampton; Caroline M Perry
Journal:  Drugs       Date:  2008       Impact factor: 9.546

5.  First Indian prospective randomized comparative study evaluating adherence and compliance of postmenopausal osteoporotic patients for daily alendronate, weekly risedronate and monthly ibandronate regimens of bisphosphonates.

Authors:  Vishal R Tandon; Sudhaa Sharma; Shagun Mahajan; Annil Mahajan; Vijay Khajuria; Zahid Gillani
Journal:  J Midlife Health       Date:  2014-01

Review 6.  European guidance for the diagnosis and management of osteoporosis in postmenopausal women.

Authors:  J A Kanis; N Burlet; C Cooper; P D Delmas; J-Y Reginster; F Borgstrom; R Rizzoli
Journal:  Osteoporos Int       Date:  2008-02-12       Impact factor: 4.507

7.  Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA.

Authors:  C Asche; R Nelson; C McAdam-Marx; M Jhaveri; X Ye
Journal:  Osteoporos Int       Date:  2009-10-02       Impact factor: 4.507
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.